Neri, Antonino

Aberrant global methylation patterns affect the molecular pathogenesis and prognosis of multiple myeloma

Walker, B. A., Wardell, C. P., Chiecchio, L., Smith, E. M., Boyd, K. D., Neri, A., Davies, F. E., Ross, F. M., & Morgan, G. J. (2011) · Blood

Multiple Myeloma Research and TreatmentsEpigenetics and DNA Methylation

Cited by 267

Targeting miR-21 Inhibits In Vitro and In Vivo Multiple Myeloma Cell Growth

Leone, E., Morelli, E., Di Martino, M. T., Amodio, N., Foresta, U., Gullà, A., Rossi, M., Neri, A., Giordano, A., Munshi, N. C., et al. (2013) · Clinical Cancer Research

Multiple Myeloma Research and TreatmentsMicroRNA in disease regulation

Cited by 219

The histone methyltransferase MMSET/WHSC1 activates TWIST1 to promote an epithelial-mesenchymal transition and invasive properties of prostate cancer

Ezponda, T., Popovic, R., Shah, M. Y., Martinez-Garcia, E., Zheng, Y., Min, D.-J., Will, C., Neri, A., Kelleher, N. L., Yu, J., et al. (2013) · Oncogene

Prostate Cancer Treatment and ResearchEpigenetics and DNA Methylation

Cited by 158

Small nucleolar RNAs as new biomarkers in chronic lymphocytic leukemia

Ronchetti, D., Mosca, L., Cutrona, G., Tuana, G., Gentile, M., Fabris, S., Agnelli, L., Ciceri, G., Matis, S., Massucco, C., et al. (2013) · BMC Medical Genomics

Chronic Lymphocytic Leukemia ResearchLymphoma Diagnosis and Treatment

Cited by 91

The expression pattern of small nucleolar and small Cajal body-specific RNAs characterizes distinct molecular subtypes of multiple myeloma

Ronchetti, D., Todoerti, K., Tuana, G., Agnelli, L., Mosca, L., Lionetti, M., Fabris, S., Colapietro, P., Miozzo, M., Ferrarini, M., et al. (2012) · Blood Cancer Journal

Multiple Myeloma Research and TreatmentsRNA modifications and cancer

Cited by 79

Homotypic and Heterotypic Activation of the Notch Pathway in Multiple Myeloma–Enhanced Angiogenesis: A Novel Therapeutic Target?

Saltarella, I., Frassanito, M. A., Lamanuzzi, A., Brevi, A., Leone, P., Desantis, V., Di Marzo, L., Bellone, M., Derudas, D., Ribatti, D., et al. (2019) · Neoplasia

Multiple Myeloma Research and TreatmentsAngiogenesis and VEGF in Cancer

Cited by 32

Specific targeting of the KRAS mutational landscape in myeloma as a tool to unveil the elicited antitumor activity

Sacco, A., Federico, C., Todoerti, K., Ziccheddu, B., Palermo, V., Giacomini, A., Ravelli, C., Maccarinelli, F., Bianchi, G., Belotti, A., et al. (2021) · Blood

Multiple Myeloma Research and TreatmentsAcute Myeloid Leukemia Research

Cited by 20

Elotuzumab plus lenalidomide and dexamethasone in relapsed/refractory multiple myeloma: Extended 3‐year follow‐up of a multicenter, retrospective clinical experience with 319 cases outside of controlled clinical trials

Bruzzese, A., Derudas, D., Galli, M., Martino, E. A., Rocco, S., Conticello, C., Califano, C., Giuliani, N., Mangiacavalli, S., Farina, G., et al. (2022) · Hematological Oncology

Multiple Myeloma Research and TreatmentsBone health and treatments

Cited by 17

Non-Coding RNAs in Multiple Myeloma Bone Disease Pathophysiology

Raimondi, L., De Luca, A., Giavaresi, G., Raimondo, S., Gallo, A., Taiana, E., Alessandro, R., Rossi, M., Neri, A., Viglietto, G., et al. (2020) · Non-Coding RNA

Multiple Myeloma Research and TreatmentsBone Metabolism and Diseases

Cited by 16